Shandong Chuangxin Pharmaceutical Research & Development Co., Ltd.

Shandong Innovative Drug Research and Development Co., Ltd. was established in 2008 and is located in Jinan High-tech Zone. As the R&D headquarters base of Shimei Pharmaceuticals, for more than ten years, the company has adhered to starting with the end in mind, taking clinical needs as the guide, customer and patient as the center, and using MH as the link. It has vigorously implemented innovation-driven strategies and focused on chiral reduction. Seven major product pipelines including Sangao drugs have been built, and nine core technology platforms represented by the new chiral drug R&D platform have been built. 300 million yuan has been invested to build a new R&D center site and a pilot production platform, and 6 general drug lines have been built. And anti-tumor GMP production line, dosage forms cover oral, injection, topical, inhalation, etc. Relying on Shimei Pharmaceuticals and using Shandong Innovation as the entrance, the company firmly establishes the business philosophy of "nurturing innovation with imitation, promoting innovation with imitation, invasiveness in imitation, and combining imitation with innovation", and closely focuses on "major diseases". , large market, large varieties" disease areas, through the differentiated R&D strategy of "first imitation, rush imitation, high-difficulty imitation" and the business model of "independent project establishment, self-research and development, self-declaration, and opportunistic transfer", forming a number of Links, multi-field services and operating capabilities can provide customers with high-end generic drug development, consistency evaluation, improved innovative drugs, innovative drug research and development and other pharmaceutical research, clinical trials, transformation of technological achievements and CDMO/CMO of high-end preparations and other supporting services Technical Services. After years of development, the company has developed a "four-wheel drive" comprehensive service capability from pharmacy to clinical research CRO, from raw materials to preparation CDM0/CMO. Based on years of R&D accumulation and rich technical achievements, the company has obtained more than 160 technical and industrial support from clinical and production registration approvals. It is a CXO comprehensive service provider that truly covers the entire industry chain of CR0, CDMO/CMO, and CS0. business and has strong market influence among CR0 companies.